Clinical Trials
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, announce the signing of an exclusive clinical trial supply agreement for oncology generics.
Through...
Clinical Trials
ERYTECH Announces Publication of its Phase 2b Trial of Eryaspase in Metastatic Pancreatic Cancer in the European Journal of Cancer
ERYTECH Pharma a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced that the full results from its Phase 2b trial evaluating eryaspase in metastatic pancreatic cancer are now published online in...
Drug Research
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to surufatinib for the treatment of pancreatic neuroendocrine tumors.
“NET is an area of significant unmet medical need. The current treatment options are very limited,” said...
Drug Research
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, announced an option, research and license agreement worth up to USD 100 million. The partnership will leverage Dewpoint’s proprietary platform for biomolecular condensates and Bayer’s...
News
DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India
DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to indispensable ingredients and unmatched expertise. At CPhI India, Nov. 26-28, the company will showcase increased capacity on both fronts, in addition to several product...
IT & Data Management
Heraeus expands cancer therapy API capacity
Heraeus Pharmaceutical Ingredients, a business line of Heraeus Precious Metals, has expanded its capacity for Platinum-based highly potent active pharmaceutical ingredients (Pt HPAPIs) with an additional production line built at the company’s headquarters in Hanau, Germany.
Heraeus is the leading...
News
India to grow strongly in 2020 as CPhI & P-MEC India opens
CPhI & P-MEC India – organised by Informa Markets – is set to open its doors to more than 43,000 attendees from 120 countries and 1,500 exhibitors, as new analysis shows a massive improvement in India’s global reputation. The...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read